BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27326252)

  • 1. Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis.
    Liao KM; Chao TB; Tian YF; Lin CY; Lee SW; Chuang HY; Chan TC; Chen TJ; Hsing CH; Sheu MJ; Li CF
    J Cancer; 2016; 7(9):1088-94. PubMed ID: 27326252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of high ubiquitin-conjugating enzyme E2 expression as a prognostic factor in nasopharyngeal carcinoma.
    Kao WC; Hsu SH; Lin CL; Lin CY; Chen SW; Chen YX; Chen CH; Lee SW; Tsao CJ; Huang WT; Chen SH; Hsiao SY
    Oncol Lett; 2022 Jun; 23(6):194. PubMed ID: 35572494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
    Xu YF; Ren XY; Li YQ; He QM; Tang XR; Sun Y; Shao JY; Jia WH; Kang TB; Zeng MS; Liu N; Ma J
    BMC Cancer; 2015 Apr; 15():332. PubMed ID: 25925041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periostin overexpression is associated with worse prognosis in nasopharyngeal carcinoma from endemic area: a cohort study.
    Wei YC; Yang SF; Chang SL; Chen TJ; Lee SW; Chen HS; Lin LC; Li CF
    Onco Targets Ther; 2018; 11():3205-3213. PubMed ID: 29881294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN3 expression is an independent prognostic factor and associated with advanced tumor stage in nasopharyngeal carcinoma.
    Chang SL; Chen TJ; Lee YE; Lee SW; Lin LC; He HL
    Int J Med Sci; 2018; 15(10):992-998. PubMed ID: 30013440
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
    Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
    Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in China.
    Liu X; Li X; Jiang N; Lei Y; Tang LL; Chen L; Zhou GQ; Sun Y; Yue D; Guo R; Mao YP; Li WF; Liu LZ; Tian L; Lin AH; Ma J
    Cancer; 2014 Jan; 120(1):68-76. PubMed ID: 24114075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
    He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
    Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma.
    Chang SL; Lee SW; Yang SF; Chien CC; Chan TC; Chen TJ; Yang CC; Li CF; Wei YC
    APMIS; 2020 Apr; 128(4):287-297. PubMed ID: 31837171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection.
    Liu YP; Li H; You R; Li JB; Liu XK; Yang AK; Guo X; Song M; Zhang Q; Guo ZM; Chen WK; Liu WW; Zou X; Hua YJ; Yang Q; Zhang YN; Sun R; Mo HY; Guo L; Lin AH; Mai HQ; Qian CN; Chen MY
    Laryngoscope; 2019 Feb; 129(2):387-395. PubMed ID: 30325027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and Prognostic Significance of Macrophage Inflammatory Protein-3 Alpha and Cystatin A in Nasopharyngeal Carcinoma.
    Tang M; Ou N; Li C; Lu A; Li J; Ma L; Zhong W; Gao J; Zheng Y; Cai Y
    Biomed Res Int; 2015; 2015():617143. PubMed ID: 26634210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic impact of RAP2A expression in patients with early and locoregionally advanced nasopharyngeal carcinoma in an endemic area.
    Lee YE; He HL; Chen TJ; Lee SW; Chang IW; Hsing CH; Li CF
    Am J Transl Res; 2015; 7(5):912-21. PubMed ID: 26175852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
    Lan XW; Zou XB; Xiao Y; Tang J; OuYang PY; Su Z; Xie FY
    PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma.
    Liu LT; Tang LQ; Chen QY; Zhang L; Guo SS; Guo L; Mo HY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):862-9. PubMed ID: 26530755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients.
    Liu LT; Chen QY; Tang LQ; Guo SS; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Qian CN; Zeng MS; Bei JX; Tan J; Chen S; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
    Cancer Res Treat; 2018 Jan; 50(1):19-29. PubMed ID: 28392551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate Decarboxylase 1 Overexpression as a Poor Prognostic Factor in Patients with Nasopharyngeal Carcinoma.
    Lee YY; Chao TB; Sheu MJ; Tian YF; Chen TJ; Lee SW; He HL; Chang IW; Hsing CH; Lin CY; Li CF
    J Cancer; 2016; 7(12):1716-1723. PubMed ID: 27698909
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of Chemoradiotherapy Regimens and Survival Among Patients With Nasopharyngeal Carcinoma: A Systematic Review and Meta-analysis.
    Zhang B; Li MM; Chen WH; Zhao JF; Chen WQ; Dong YH; Gong X; Chen QY; Zhang L; Mo XK; Luo XN; Tian J; Zhang SX
    JAMA Netw Open; 2019 Oct; 2(10):e1913619. PubMed ID: 31626318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients.
    Jiang R; Zou X; Hu W; Fan YY; Yan Y; Zhang MX; You R; Sun R; Luo DH; Chen QY; Huang PY; Hua YJ; Guo L; Chen MY
    Tumour Biol; 2015 Sep; 36(10):7775-87. PubMed ID: 25944165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma.
    Jiang F; Yu W; Zeng F; Cheng G; Xu J; Yang S; Shui Y; Wu D; Yu XF; Wei Q
    BMC Cancer; 2019 May; 19(1):503. PubMed ID: 31138162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma.
    Tai HC; Huang HY; Lee SW; Lin CY; Sheu MJ; Chang SL; Wu LC; Shiue YL; Wu WR; Lin CM; Li CF
    J Clin Pathol; 2012 Mar; 65(3):248-53. PubMed ID: 22081787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.